Fixational Eye Movement Waveforms in Amblyopia: Characteristics of Fast and Slow Eye Movements.
Eye movement
binocular viewing
fixational stability
microsaccades
saccades
Journal
Journal of eye movement research
ISSN: 1995-8692
Titre abrégé: J Eye Mov Res
Pays: Switzerland
ID NLM: 101532119
Informations de publication
Date de publication:
05 Jul 2019
05 Jul 2019
Historique:
entrez:
8
4
2021
pubmed:
5
7
2019
medline:
5
7
2019
Statut:
epublish
Résumé
Fixational eye movements comprise of fast microsaccades alternating with slow intersaccadic drifts. These physiologic eye movements play an important role in visual perception. Amblyopic patients are known to have fixation instability, particularly of the amblyopic eye. We examined eye movement abnormalities that contribute to this instability. We found that fixation stability is affected by the presence of fusion maldevelopment nystagmus (FMN). However, some amblyopes can have nystagmus without nasally directed slow phases and reversal in direction of the quick phase on ocular occlusion, features seen in FMN. In patients without nystagmus, we found increased amplitude of fixational saccades and inter-saccadic drifts. We categorized amblyopia patients by type (anisometropic, strabismic, or mixed) and eye movement waveform (no nystagmus, nystagmus without FMN, and FMN). We found specific fast and slow eye movement abnormalities of the fellow and amblyopic eye during fellow, amblyopic and both eyes viewing conditions across eye movement waveforms and types of amblyopia. These eye movement abnormalities can serve as biomarkers that can predict the impact of amblyopia as measured by visual acuity and stereopsis. Evaluation of fixational eye movements in amblyopia could be important to diagnose these common eye diseases and predict treatment effectiveness.
Identifiants
pubmed: 33828757
doi: 10.16910/jemr.12.6.9
pmc: PMC7962684
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare that the contents of the article are in agreement with the ethics described in http://biblio.unibe.ch/portale/elibrary/BOP/jemr/ethics.html and that there is no conflict of interest regarding the publication of this paper.
Références
Vision Res. 2019 Jan;154:14-20
pubmed: 30389388
Vis Neurosci. 2018 Jan;35:E016
pubmed: 29905122
Vision Res. 1969 Feb;9(2):245-65
pubmed: 5774207
Strabismus. 2000 Sep;8(3):195-9
pubmed: 11187931
Invest Ophthalmol Vis Sci. 2014 Aug 05;55(9):5687-57015
pubmed: 25097239
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1635-42
pubmed: 27050880
Ophthalmic Physiol Opt. 1987;7(4):461-7
pubmed: 3454923
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2531-5
pubmed: 25678690
Strabismus. 1996;4(4):171-7
pubmed: 21314368
Philos Trans R Soc Lond B Biol Sci. 1977 Apr 26;278(961):377-409
pubmed: 19791
JAMA Ophthalmol. 2019 Feb 1;137(2):167-174
pubmed: 30452518
Invest Ophthalmol Vis Sci. 2008 May;49(5):1872-8
pubmed: 18223249
J Vis. 2003;3(5):380-405
pubmed: 12875634
J Neurosci. 2012 Jul 4;32(27):9194-204
pubmed: 22764228
Eye (Lond). 1996;10 ( Pt 2):274-81
pubmed: 8776460
J Vis. 2014 Feb 25;14(2):
pubmed: 24569984
Psychol Sci. 2004 Jun;15(6):431-6
pubmed: 15147499
Strabismus. 2018 Sep;26(3):118-121
pubmed: 30060696
Neuron. 2006 Jan 19;49(2):297-305
pubmed: 16423702
J Vis. 2008 Dec 18;8(14):21.1-18
pubmed: 19146322
Exp Eye Res. 2019 Jun;183:29-37
pubmed: 30006273
Br J Ophthalmol. 1988 Jan;72(1):44-9
pubmed: 3342218
Front Integr Neurosci. 2014 Jul 07;8:52
pubmed: 25071480
J Am Optom Assoc. 1979 Nov;50(11):1251-8
pubmed: 521578
Seeing Perceiving. 2012;25(5):449-69
pubmed: 22370759
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5743-5753
pubmed: 29114840
Graefes Arch Clin Exp Ophthalmol. 2006 Apr;244(4):465-71
pubmed: 16170532
J Neuroophthalmol. 2010 Sep;30(3):276-83
pubmed: 20818206
Brain. 1992 Oct;115 ( Pt 5):1303-21
pubmed: 1422790
PLoS One. 2016 Mar 01;11(3):e0149953
pubmed: 26930079
J Neurophysiol. 1963 Nov;26:1003-17
pubmed: 14084161
Invest Ophthalmol Vis Sci. 1978 Aug;17(8):746-53
pubmed: 681134
Bull Soc Belge Ophtalmol. 1989;232:7-12
pubmed: 2490389
Nature. 1982 Oct 14;299(5884):583-91
pubmed: 6811951
Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):765-70
pubmed: 12271375
PLoS One. 2017 Apr 13;12(4):e0175295
pubmed: 28406944
JAMA Ophthalmol. 2016 Jan;134(1):63-9
pubmed: 26562632
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4506-4517
pubmed: 30208418
J Neurosci. 1998 Aug 15;18(16):6411-24
pubmed: 9698332
Vision Res. 2015 Sep;114:87-99
pubmed: 25668775
Invest Ophthalmol Vis Sci. 2012 Aug 09;53(9):5386-94
pubmed: 22789926
Invest Ophthalmol Vis Sci. 2013 Mar 19;54(3):1998-2003
pubmed: 23372053
Eye (Lond). 1998;12 ( Pt 2):167-72
pubmed: 9683932
PLoS One. 2013;8(2):e56556
pubmed: 23441203
Restor Neurol Neurosci. 2012;30(6):445-62
pubmed: 23001901
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1087-95
pubmed: 26968739
Nat Rev Neurosci. 2004 Mar;5(3):229-40
pubmed: 14976522
Science. 1967 Mar 24;155(3769):1577-9
pubmed: 6020487
J Vis. 2008 Nov 04;8(14):15.1-9
pubmed: 19146316
Hum Neurobiol. 1982;1(2):97-109
pubmed: 6764462
Br J Ophthalmol. 2018 Feb;102(2):253-259
pubmed: 28698242